Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer

Cancer

Volumn 118, Issue 4, 2012, Pages 937-946

  Zhou, Feng ^a   He, Xianli ^a   Liu, Hanqiang ^b   Zhu, Yong ^c   Jin, Tianbo ^d   Chen, Chao ^d   Qu, Falin ^a   Li, Yunming ^b   Bao, Guoqiang ^a   Chen, Zhinan ^b   Xing, Jinliang ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NORTHWEST UNIVERSITY   (China)

Author keywords

circadian gene; CLOCK; colorectal cancer; prognosis; single nucleotide polymorphism

Indexed keywords

ADULT; ARTICLE; BRAIN AND MUSCLE ARNT LIKE PROTEIN 1 GENE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CHINESE; CIRCADIAN LOCOMOTOR OUTPUT CYCLES KAPUT GENE; COLON RESECTION; COLORECTAL CANCER; CONTROLLED STUDY; FEEDBACK SYSTEM; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC REGULATION; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NEURONAL PAS DOMAIN PROTEIN 2 GENE; ONCOGENE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; SURVIVAL TIME; WILD TYPE; AGED; BMAL1 GENE; CANCER SURGERY; CIRCADIAN RHYTHM; CLOCK GENE; COHORT ANALYSIS; GENE; GENETIC VARIABILITY; GENOTYPE; HAN CHINESE; HETEROZYGOTE; HOMOZYGOTE; NPAS2 GENE; POSITIVE FEEDBACK;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ARNTL TRANSCRIPTION FACTORS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CHINA; CIRCADIAN CLOCKS; CLOCK PROTEINS; COLECTOMY; COLORECTAL NEOPLASMS; FEEDBACK, PHYSIOLOGICAL; FEMALE; GENOTYPE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

TRANSCRIPTION FACTOR ARNTL; TRANSCRIPTION FACTOR CLOCK;

EID: 84856782818     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26348     Document Type: Article

References (45)

1. Lowrey PL, Takahashi JS,. Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu Rev Genomics Hum Genet. 2004; 5: 407-441.
2. Kondratov RV, Gorbacheva VY, Antoch MP,. The role of mammalian circadian proteins in normal physiology and genotoxic stress responses. Curr Top Dev Biol. 2007; 78: 173-216.
3. Shearman LP, Sriram S, Weaver DR, et al. Interacting molecular loops in the mammalian circadian clock. Science. 2000; 288: 1013-1019.
4. Lee C, Etchegaray JP, Cagampang FR, Loudon AS, Reppert SM,. Posttranslational mechanisms regulate the mammalian circadian clock. Cell. 2001; 107: 855-867.
5. Kondratov RV, Chernov MV, Kondratova AA, Gorbacheva VY, Gudkov AV, Antoch MP,. BMAL1-dependent circadian oscillation of nuclear CLOCK: posttranslational events induced by dimerization of transcriptional activators of the mammalian clock system. Genes Dev. 2003; 17: 1921-1932.
6. DeBruyne JP, Weaver DR, Reppert SM,. CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock. Nat Neurosci. 2007; 10: 543-545.
7. Asher G, Schibler U,. A CLOCK-less clock. Trends Cell Biol. 2006; 16: 547-549.
8. Kume K, Zylka MJ, Sriram S, et al. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell. 1999; 98: 193-205.
9. Dunlap JC,. Molecular bases for circadian clocks. Cell. 1999; 96: 271-290.
10. Turek FW, Joshu C, Kohsaka A, et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science. 2005; 308: 1043-1045.
11. Woon PY, Kaisaki PJ, Braganca J, et al. Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes. Proc Natl Acad Sci U S A. 2007; 104: 14412-14417.
12. Scott EM, Carter AM, Grant PJ,. Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man. Int J Obes (Lond). 2008; 32: 658-662.
13. Sookoian S, Gemma C, Gianotti TF, Burgueno A, Castano G, Pirola CJ,. Genetic variants of Clock transcription factor are associated with individual susceptibility to obesity. Am J Clin Nutr. 2008; 87: 1606-1615.
14. Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007; 8: 1065-1066.
15. Irvine D, Davies DM,. British Airways flightdeck mortality study, 1950-1992. Aviat Space Environ Med. 1999; 70: 548-555.
16. Pukkala E, Aspholm R, Auvinen A, et al. Cancer incidence among 10,211 airline pilots: a Nordic study. Aviat Space Environ Med. 2003; 74: 699-706.
17. Zhu Y, Leaderer D, Guss C, et al. Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma. Int J Cancer. 2007; 120: 432-435.
18. Zhu Y, Stevens RG, Leaderer D, et al. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk. Breast Cancer Res Treat. 2008; 107: 421-425.
19. Taniguchi H, Fernandez AF, Setien F, et al. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies. Cancer Res. 2009; 69: 8447-8454.
20. Yi C, Mu L, de la Longrais IA, et al. The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer. Breast Cancer Res Treat. 2010; 120: 663-669.
21. Lin YM, Chang JH, Yeh KT, et al. Disturbance of circadian gene expression in hepatocellular carcinoma. Mol Carcinog. 2008; 47: 925-933.
22. Filipski E, King VM, Li X, et al. Host circadian clock as a control point in tumor progression. J Natl Cancer Inst. 2002; 94: 690-697.
23. Center MM, Jemal A, Smith RA, Ward E,. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009; 59: 366-378.
24. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60: 277-300.
25. Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000; 124: 979-994.
26. Chang GJ, Hu CY, Eng C, Skibber JM, Rodriguez-Bigas MA,. Practical application of a calculator for conditional survival in colon cancer. J Clin Oncol. 2009; 27: 5938-5943.
27. Johnson JA,. Pharmacogenetics: potential for individualized drug therapy through genetics. Trends Genet. 2003; 19: 660-666.
28. Yang JJ, Cheng C, Yang W, et al. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA. 2009; 301: 393-403.
29. Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009; 461: 399-401.
30. Ciarleglio CM, Ryckman KK, Servick SV, et al. Genetic differences in human circadian clock genes among worldwide populations. J Biol Rhythms. 2008; 23: 330-340.
31. Xu Z, Taylor JA,. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res. 2009; 37: W600-W605.
32. Zhu Y, Stevens RG, Hoffman AE, et al. Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Res. 2009; 69: 9315-9322.
33. Hughes M, Deharo L, Pulivarthy SR, et al. High-resolution time course analysis of gene expression from pituitary. Cold Spring Harb Symp Quant Biol. 2007; 72: 381-386.
34. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H,. Control mechanism of the circadian clock for timing of cell division in vivo. Science. 2003; 302: 255-259.
35. Fu L, Pelicano H, Liu J, Huang P, Lee C,. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 2002; 111: 41-50.
36. Vafa O, Wade M, Kern S, et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell. 2002; 9: 1031-1044.
37. Grechez-Cassiau A, Rayet B, Guillaumond F, Teboul M, Delaunay F,. The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J Biol Chem. 2008; 283: 4535-4542.
38. Sato K, Miyahara M, Saito T, Kobayashi M,. c-myc mRNA overexpression is associated with lymph node metastasis in colorectal cancer. Eur J Cancer. 1994; 30A: 1113-1117.
39. Ogino S, Nosho K, Shima K, et al. p21 expression in colon cancer and modifying effects of patient age and body mass index on prognosis. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2513-2521.
40. Doi M, Hirayama J, Sassone-Corsi P,. Circadian regulator CLOCK is a histone acetyltransferase. Cell. 2006; 125: 497-508.
41. Roy PG, Thompson AM,. Cyclin D1 and breast cancer. Breast. 2006; 15: 718-727.
42. Garaulet M, Corbalan MD, Madrid JA, et al. CLOCK gene is implicated in weight reduction in obese patients participating in a dietary programme based on the Mediterranean diet. Int J Obes (Lond). 2010; 34: 516-523.
43. Calati R, Gaspar-Barba E, Yukler A, Serretti A,. T3111C clock single nucleotide polymorphism and mood disorders: a meta-analysis. Chronobiol Int. 2010; 27: 706-721.
44. Garaulet M, Lee YC, Shen J, et al. Genetic variants in human CLOCK associate with total energy intake and cytokine sleep factors in overweight subjects (GOLDN population). Eur J Hum Genet. 2010; 18: 364-369.
45. Hoffman AE, Yi CH, Zheng T, et al. CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses. Cancer Res. 2010; 70: 1459-1468.